These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17825250)

  • 1. Rho-kinase regulates endothelin-1-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts.
    Tokuda H; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Doi T; Harada A; Takai S; Kozawa O
    Biochem Biophys Res Commun; 2007 Nov; 362(4):799-804. PubMed ID: 17825250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Kato K; Otsuka T; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Int J Mol Med; 2011 Oct; 28(4):653-8. PubMed ID: 21750859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):27-32. PubMed ID: 18586382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Hanai Y; Adachi S; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):41-6. PubMed ID: 18771907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-kinase limits BMP-4-stimulated osteocalcin synthesis in osteoblasts: regulation of the p38 MAP kinase pathway.
    Kondo A; Tokuda H; Matsushima-Nishiwaki R; Kuroyanagi G; Yamamoto N; Mizutani J; Kozawa O; Otsuka T
    Life Sci; 2014 Feb; 96(1-2):18-25. PubMed ID: 24368139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
    Hanai Y; Tokuda H; Ishisaki A; Matsushima-Nishiwaki R; Nakamura N; Yoshida M; Takai S; Ohta T; Kozawa O
    Mol Cell Endocrinol; 2006 Jun; 251(1-2):42-8. PubMed ID: 16616413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL)-17 enhances prostaglandin F(2 alpha)-stimulated IL-6 synthesis in osteoblasts.
    Tokuda H; Kozawa O; Uematsu T
    Prostaglandins Leukot Essent Fatty Acids; 2002 Apr; 66(4):427-33. PubMed ID: 12054913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
    Ishisaki A; Tokuda H; Yoshida M; Hirade K; Kunieda K; Hatakeyama D; Shibata T; Kozawa O
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):189-95. PubMed ID: 15062557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts.
    Natsume H; Tokuda H; Adachi S; Takai S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Niida S; Mizutani J; Kozawa O; Otsuka T
    Bone; 2010 Apr; 46(4):1068-74. PubMed ID: 20114091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
    Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
    Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Rho-kinase in prostaglandin E(1)-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblast-like MC3T3-E1 cells.
    Adachi S; Tokuda H; Matsushima-Nishiwaki R; Kato K; Natsume H; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Prostaglandins Other Lipid Mediat; 2009 Nov; 90(1-2):1-6. PubMed ID: 19524699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc suppresses IL-6 synthesis by prostaglandin F2alpha in osteoblasts: inhibition of phospholipase C and phospholipase D.
    Hatakeyama D; Kozawa O; Otsuka T; Shibata T; Uematsu T
    J Cell Biochem; 2002; 85(3):621-8. PubMed ID: 11968002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
    J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Kuno M; Takai S; Matsushima-Nishiwaki R; Minamitani C; Mizutani J; Otsuka T; Harada A; Adachi S; Kozawa O; Tokuda H
    Biochem Pharmacol; 2009 Jan; 77(2):196-203. PubMed ID: 18996357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts.
    Kondo A; Otsuka T; Kato K; Natsume H; Kuroyanagi G; Mizutani J; Ito Y; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2012 Dec; 30(6):1487-92. PubMed ID: 23064268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
    Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
    Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase positively regulates FGF-2-stimulated VEGF synthesis in osteoblasts.
    Kato K; Tokuda H; Adachi S; Matsushima-Nishiwaki R; Natsume H; Yamakawa K; Gu Y; Otsuka T; Kozawa O
    Biochem Biophys Res Commun; 2010 Sep; 400(1):123-7. PubMed ID: 20708602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
    Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.